# The Application of Balanced Propofol Sedation in Fiberoptic Bronchoscopy

> **NCT06116955** · — · COMPLETED · sponsor: **The Affiliated Hospital of Qingdao University** · enrollment: 424 (actual)

## Conditions studied

- Bronchoscopy

## Interventions

- **DRUG:** Midazolam and sufentanil
- **DRUG:** Midazolam, sufentanil and propofol
- **DRUG:** Remazolam and sufentanil.
- **DRUG:** Remazolam, sufentanil and propofol

## Key facts

- **NCT ID:** NCT06116955
- **Lead sponsor:** The Affiliated Hospital of Qingdao University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-21
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-01-01
- **Target enrollment:** 424 (ACTUAL)
- **Last updated:** 2024-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06116955

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06116955, "The Application of Balanced Propofol Sedation in Fiberoptic Bronchoscopy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06116955. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*